Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Chris Lange | Jun 29, 2016 at 9:56 AM EDT

Why Tesaro Is Skyrocketing

Tesaro, Inc. (NASDAQ: TSRO) is watching its shares make a significant gain on Wednesday after the company released positive late-stage…

Jon C. Ogg | Jun 28, 2016 at 12:01 PM EDT

5 Top Biotechs Where Future Multi-Billion Dollar Drug Pipelines are Valued Almost at Zero

[cnxvideo id=”655353″ placement=”ros”]Sometimes market volatility and outside shocks create a rift between market prices and real value. That may currently…

Chris Lange | Jun 28, 2016 at 11:39 AM EDT

inVentiv Updates IPO Filing

inVentiv Group Holdings filed an amended Form S-1 with the U.S. Securities and Exchange Commission (SEC) regarding its initial public…

Chris Lange | Jun 28, 2016 at 9:14 AM EDT

Why Regulus Is Tanking

Regulus Therapeutics Inc. (NASDAQ: RGLS) saw its shares cut in half early Tuesday morning following news of a clinical hold…

Chris Lange | Jun 27, 2016 at 11:46 AM EDT

DENTSPLY Slides on Acquisition News

DENTSPLY International Inc. (NASDAQ: XRAY) saw its shares pull back slightly in Monday’s session following news of an acquisition. The…

Chris Lange | Jun 27, 2016 at 10:21 AM EDT

Medtronic Moves to Acquire Heartware

Heartware International (NASDAQ: HTWR) is watching its shares absolutely skyrocket in Monday’s session despite the huge market downturn from the…

Chris Lange | Jun 27, 2016 at 9:44 AM EDT

Medpace Files for IPO

Medpace Holdings, Inc. filed a Form S-1 with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). There…

Chris Lange | Jun 27, 2016 at 8:11 AM EDT

Short Sellers Increase Bets Against Major Pharmaceutical Stocks

The short interest data have been released for the June 15 settlement date. Pharmaceutical companies usually are involved in a…

Chris Lange | Jun 27, 2016 at 7:55 AM EDT

Short Sellers Run for Cover From Major Biotechs

The short interest data are out for the June 15 settlement date. Biotech companies are considered a riskier group of…

Lee Jackson | Jun 24, 2016 at 8:56 AM EDT

J.P. Morgan Very Positive on 3 Battered Specialty Pharmaceutical Stocks

[cnxvideo id=”655379″ placement=”ros”]Ever since the infamous Hillary Clinton tweet about pharmaceutical drug pricing, the biotech and specialty pharmaceutical stocks have…

Lee Jackson | Jun 23, 2016 at 10:55 AM EDT

A Biotech and a Medical Device Stock, Each With Massive Upside Potential

Two recent Wedbush research reports focus is on health care companies that not only have data that could prove to…

Chris Lange | Jun 22, 2016 at 11:35 AM EDT

Why Nymox Pharmaceutical Took Off

Nymox Pharmaceutical shares made solid headway in Wednesday’s session on positive results from a cancer trial.

Chris Lange | Jun 21, 2016 at 12:10 PM EDT

Medgenics Announces Pricing of Secondary Offering

Medgenics saw its shares drop on Tuesday after the company announced the pricing of its secondary offering.

Chris Lange | Jun 21, 2016 at 10:40 AM EDT

With Acquisitions, Will Impax Become the Next Great Generic Drug Seller?

Impax Laboratories plans to take on a substantial portfolio of generic drugs in a transaction that will be immediately accretive…

Douglas A. McIntyre | Jun 21, 2016 at 9:40 AM EDT

US Health Care Expense Could Be $2.6 Trillion Below Forecast

Health care costs could be $2.6 trillion less from 2014 to 2019, well below earlier forecasts, according to the Robert…

1 … 204 205 206 207 208 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Why Tesaro Is Skyrocketing

5 Top Biotechs Where Future Multi-Billion Dollar Drug Pipelines are Valued Almost at Zero

inVentiv Updates IPO Filing

Why Regulus Is Tanking

DENTSPLY Slides on Acquisition News

Medtronic Moves to Acquire Heartware

Medpace Files for IPO

Short Sellers Increase Bets Against Major Pharmaceutical Stocks

Short Sellers Run for Cover From Major Biotechs

J.P. Morgan Very Positive on 3 Battered Specialty Pharmaceutical Stocks

A Biotech and a Medical Device Stock, Each With Massive Upside Potential

Why Nymox Pharmaceutical Took Off

Medgenics Announces Pricing of Secondary Offering

With Acquisitions, Will Impax Become the Next Great Generic Drug Seller?

US Health Care Expense Could Be $2.6 Trillion Below Forecast

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that's now reaching retirees' statements

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Live: Navitas Semiconductor Q1 Earnings Tonight. Can the 676% Surge Survive the Print?

Health and Healthcare Articles

All Health and Healthcare Articles

Why Tesaro Is Skyrocketing

5 Top Biotechs Where Future Multi-Billion Dollar Drug Pipelines are Valued Almost at Zero

inVentiv Updates IPO Filing

Why Regulus Is Tanking

DENTSPLY Slides on Acquisition News

Medtronic Moves to Acquire Heartware

Medpace Files for IPO

Short Sellers Increase Bets Against Major Pharmaceutical Stocks

Short Sellers Run for Cover From Major Biotechs

J.P. Morgan Very Positive on 3 Battered Specialty Pharmaceutical Stocks

A Biotech and a Medical Device Stock, Each With Massive Upside Potential

Why Nymox Pharmaceutical Took Off

Medgenics Announces Pricing of Secondary Offering

With Acquisitions, Will Impax Become the Next Great Generic Drug Seller?

US Health Care Expense Could Be $2.6 Trillion Below Forecast

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

Featured Reads

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that's now reaching retirees' statements

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check